Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Axcella Health Inc. (AXLA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events ...
08/18/2023 ARS Form ARS - Annual Report to Security Holders:
08/18/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/07/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/04/2023 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11  Interactive Data
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
06/29/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previous...
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
03/30/2023 8-K Quarterly results
02/24/2023 4 Koziel Margaret (Chief Medical Officer) has filed a Form 4 on Axcella Health Inc.
Txns: Granted 70,000 options to buy @ $0.6759, valued at $47.3k
02/24/2023 4 Hinshaw William (President & CEO) has filed a Form 4 on Axcella Health Inc.
Txns: Granted 275,000 options to buy @ $0.6759, valued at $185.9k
02/24/2023 4 Fehlner Paul (SVP & Chief Legal Officer) has filed a Form 4 on Axcella Health Inc.
Txns: Granted 70,000 options to buy @ $0.6759, valued at $47.3k
02/14/2023 SC 13G/A HarbourVest Partners L.P. reports a 8.4% stake in Axcella Health Inc.
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2023 SC 13G/A FMR LLC reports a 15% stake in AXCELLA HEALTH INC
12/15/2022 8-K Quarterly results
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/01/2022 8-K Quarterly results
10/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2022 4 Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Bought 2,743,902 shares @ $1.64, valued at $4.5M
Bought 2,757,333 shares @ $1.64, valued at $4.5M
Bought 914,634 shares @ $1.64, valued at $1.5M
Bought 919,111 shares @ $1.64, valued at $1.5M
Bought 3,048,780 shares @ $1.64, valued at $5M
10/17/2022 SC 13D/A Flagship VentureLabs IV, LLC reports a 39.8% stake in AXCELLA HEALTH INC.
10/17/2022 3 Flagship Pioneering Inc. (10% Owner) has filed a Form 3 on Axcella Health Inc.
10/17/2022 3 Rosiello Robert L. (Director) has filed a Form 3 on Axcella Health Inc.
10/17/2022 3 NISSEN TORBEN STRAIGHT (Director) has filed a Form 3 on Axcella Health Inc.
10/17/2022 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Bought 3,658,536 shares @ $1.64, valued at $6M
10/13/2022 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Letter re: Securities Registered under Registration Statement on Form S-3",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of October 13, 2022, between Axcella Health Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser a..."
10/13/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/29/2022 8-K Quarterly results
09/23/2022 D Form D - Notice of Exempt Offering of Securities:
09/23/2022 SC 13D/A Flagship VentureLabs IV, LLC reports a 35.8% stake in AXCELLA HEALTH INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy